Concepedia

Andy Garnham

AG

4

Publications

103

Citations

4

H-Index

2009

Active since

Affiliations

Astellas Pharma (United Kingdom)(Current)

Astellas Pharma (Netherlands)

Creativ-Ceutical (France)

Andy Garnham is an author at Astellas Pharma (United Kingdom) specializing in medicine, surgery, and outcomes research.

Top concepts

Publications per year

2009–2015

4

Publications

4

Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom

Jameel Nazir, Khaled Maman, Mohamed-Elmoctar Neine et al. · Value in Health · 2015 · 33 citations · Full text

, , +8

Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom

Samuel Aballéa, Khaled Maman, K. Thokagevistk et al. · Clinical Drug Investigation · 2014 · 26 citations · Full text

Application of a locally conservative Galerkin (LCG) method for modelling blood flow through a patient‐specific carotid bifurcation

Rhodri L. T. Bevan, Perumal Nithiarasu, Raoul van Loon et al. · International Journal for Numerical Methods in Fluids · 2010 · 24 citations

, , +15

Health-related quality of life improvement following surgical treatment of primary hyperparathyroidism in a United Kingdom population

Kuan Juen Leong, Rachel Sam, Andy Garnham · The Surgeon · 2009 · 20 citations

, , +8

Rows per page

1–4 of 4